Financings in Brief: InSite Vision
This article was originally published in The Gray Sheet
Executive Summary
InSite Vision: Raises $8 mil. through private placements, including $7 mil. in convertible preferred stock to a group of institutional investors led by Credit Suisse First Boston, and $1 mil. in common stock to ophthalmic product firm Bausch & Lomb. The financing boosts the firm's cash and cash equivalents to more than $11 mil. and will enable continued development of its genetic technology-based tools for diagnosis and prognosis of glaucoma, the firm states...